SGRY
Surgery Partners Inc
13.30$
-0.7%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 14.5% | 14.8% | 15.7% | 12.2% | 12.6% | 10.5% | 14.8% | 15.5% | 13.8% | 13.0% | 14.2% | 14.0% | |
| 4.0% | 2.7% | 3.0% | 3.8% | 3.9% | 1.8% | 5.9% | 6.4% | 4.2% | 2.8% | 3.4% | 2.9% | |
| 4.0% | 2.7% | 3.0% | 3.8% | 3.9% | 1.8% | 5.9% | 6.4% | 4.2% | 2.8% | 3.4% | 2.9% | |
| 8.3% | 8.8% | 9.9% | 6.4% | 6.8% | 6.5% | 7.1% | 7.0% | 6.8% | 7.2% | 7.3% | 7.3% | |
| 1.3% | 1.2% | 1.2% | 1.0% | 0.9% | 0.9% | 1.0% | 1.0% | 1.1% | 1.1% | 1.1% | 1.2% | |
| 9.4% | 8.8% | 8.9% | 8.6% | 9.1% | 16.4% | 15.8% | 15.6% | 17.3% | – | – | – | |
| 69.9% | 66.8% | 67.5% | 72.4% | 72.3% | 67.8% | 64.1% | 63.9% | 61.9% | 62.9% | 64.2% | 63.0% | |
| 3.0% | 2.5% | 2.1% | 1.3% | 1.2% | 0.9% | 0.9% | 0.7% | 0.6% | 0.8% | 0.6% | 0.5% | |
| 88.1% | 100.0% | 100.0% | 100.0% | 100.0% | 66.1% | 70.0% | 62.4% | 50.9% | 51.1% | 53.9% | 57.2% | |
| 7.6% | 8.6% | 8.1% | 6.6% | 7.5% | 7.9% | 10.3% | 8.8% | 7.4% | 7.6% | 7.9% | 7.5% | |
| 1.2% | 1.3% | 1.2% | 1.3% | 1.2% | 1.9% | 1.9% | 1.6% | 1.5% | 1.6% | 1.8% | 1.7% | |
| 2.3% | 2.2% | 2.2% | 1.8% | 1.8% | 1.9% | 1.9% | 2.0% | 2.3% | 2.5% | 2.6% | 2.5% | |
| 72.1% | 58.3% | 61.4% | 46.1% | 48.6% | 50.3% | 51.6% | 47.1% | 38.3% | 39.3% | 41.4% | 43.7% | |
| -14.2% | -0.2% | 0.4% | 14.2% | 8.7% | 13.8% | 10.2% | 17.8% | 29.9% | 28.9% | 22.7% | 20.8% | |
| -17.3% | -15.2% | -13.5% | -0.9% | -5.3% | -6.3% | -8.0% | -8.2% | -8.3% | -8.3% | -9.3% | -9.9% | |
| 2.6% | 1.8% | 2.1% | 1.1% | 1.0% | 1.0% | 0.9% | 1.2% | 1.4% | 1.8% | 1.6% | 1.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.